Long-term Safety and Efficacy of Eculizumab in Asian Patients With Aquaporin-4 Immunoglobulin G-positive Neuromyelitis Optica Spectrum Disorder

被引：0
|
作者：
Fujihara, K. [1 ,2 ,3 ]
Berthele, A. [4 ]
Kim, H. J. [5 ]
Levy, M. [6 ,7 ,8 ]
Palace, J. [9 ]
Nakashima, I. [1 ,10 ]
Totolyan, N. [11 ]
Viswanathan, S. [12 ]
Wang, K-C. [13 ,14 ]
Pace, A. [15 ]
Armstrong, R. [15 ]
Carrillo-Infante, C. [15 ]
Miller, L. [15 ]
Wingerchuk, D. M. [16 ]
Pittock, S. J. [17 ]
机构：
[1] Tohoku Univ, Sendai, Miyagi, Japan
[2] Fukushima Med Univ, Fukushima, Japan
[3] Southern TOHOKU Res Inst Neurosci STRINS, Koriyama, Fukushima, Japan
[4] Tech Univ Munich, Klinikum Rechts Isar, Munich, Germany
[5] Natl Canc Ctr, Res Inst & Hosp, Goyang, South Korea
[6] Johns Hopkins Univ, Baltimore, MD USA
[7] Massachusetts Gen Hosp, Boston, MA 02114 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] John Radcliffe Hosp, Oxford, England
[10] Tohoku Med & Pharmaceut Univ, Sendai, Miyagi, Japan
[11] First Pavlov State Med Univ St Petersburg, St Petersburg, Russia
[12] Kuala Lumpur Hosp, Kuala Lumpur, Malaysia
[13] Cheng Hsin Gen Hosp, Taipei, Taiwan
[14] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[15] Alexion Pharmaceut, Boston, MA USA
[16] Mayo Clin, Scottsdale, AZ USA
[17] Mayo Clin, Rochester, MN USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-106
引用
收藏
页码：NP84 / NP85
页数：2
相关论文
共 50 条
  • [31] Long-term safety and effectiveness of eculizumab in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: a 2-year interim analysis of post-marketing surveillance in Japan
    Nakashima, Ichiro
    Nakahara, Jin
    Yokote, Hiroaki
    Manabe, Yasuhiro
    Okamura, Kazumi
    Hasegawa, Kou
    Fujihara, Kazuo
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16
  • [32] Benefit of eculizumab for a broad range of patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: findings from prevent
    Fujihara, K.
    Berthele, A.
    Kim, H. J.
    Levy, M.
    Nakashima, I.
    Oreja-Guevara, C.
    Palace, J.
    Pittock, S.
    Terzi, M.
    Totolyan, N.
    Viswanathan, S.
    Wang, K. -C.
    Pace, A.
    Yountz, M.
    Miller, L.
    Tanvir, I.
    Armstrong, R.
    Wingerchuk, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 447 - 448
  • [33] Long-Term Eculizumab in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Relapse-Risk Reduction and Safety in PREVENT and its Completed Open-Label Extension
    Fujihara, Kazuo
    Berthele, Achim
    Wingerchuk, Dean
    Palace, Jacqueline
    Levy, Michael
    Kim, Ho Jin
    Nakashima, Ichiro
    Oreja-Guevara, Celia
    Wang, Kai-Chen
    Shang, Shulian
    Yountz, Marcus
    Pittock, Sean
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (07) : NP22 - NP23
  • [34] INDIRECT COMPARISON ANALYSIS OF UNITED STATES FOOD AND DRUG ADMINISTRATION-APPROVED TREATMENT OPTIONS FOR ADULTS WITH AQUAPORIN-4 IMMUNOGLOBULIN G-POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER
    Wingerchuk, D.
    Pittock, S. J.
    Levy, M.
    Fujihara, K.
    Nakashima, I
    Paul, F.
    Kielhorn, A.
    Royston, M.
    Tanvir, I
    Zhang, I
    VALUE IN HEALTH, 2022, 25 (01) : S19 - S19
  • [35] Aquaporin-4 antibody positive neuromyelitis optica spectrum disorder associated with esophageal cancer
    Kon, Tomoya
    Ueno, Tatsuya
    Suzuki, Chieko
    Nunomura, Jinichi
    Igarashi, Shohei
    Sato, Tsugumi
    Tomiyama, Masahiko
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 309 : 38 - 40
  • [36] Endothelial damage in patients with neuromyelitis optica spectrum disorder with aquaporin-4 IgG
    Kuroda, Hiroshi
    Takai, Yoshiki
    Nishiyama, Shuhei
    Takahashi, Toshiyuki
    Misu, Tatsuro
    Nakashima, Ichiro
    Fujihara, Kazuo
    Aoki, Masashi
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (09) : NP77 - NP78
  • [37] Endothelial damage in patients with neuromyelitis optica spectrum disorder with aquaporin-4 IgG
    Kuroda, H.
    Takai, Y.
    Nishiyama, S.
    Takahashi, T.
    Misu, T.
    Nakashima, I.
    Fujihara, K.
    Aoki, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 230 - 230
  • [38] Long-term efficacy and safety of rituximab in the treatment of neuromyelitis Optica Spectrum disorder
    Hayes, Michael T. G.
    Adam, Robert J.
    McCombe, Pamela A.
    Walsh, Michael
    Blum, Stefan
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2024, 10 (02)
  • [39] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
    Park, Su Yeon
    Kwon, Young Nam
    Kim, Sunyoung
    Kim, Seung-Hyun
    Kim, Jong Kuk
    Kim, Jun-Soon
    Nam, Tai-Seung
    Min, Young Gi
    Park, Kyung Seok
    Park, Jin-Sung
    Seok, Jin Myoung
    Sung, Jung-Joon
    Sohn, Eunhee
    Shin, Kyong Jin
    Shin, Jin-Hong
    Shin, Ha Young
    Oh, Seong-il
    Oh, Jeeyoung
    Yoon, Byeol-A
    Lee, Sanggon
    Lee, Jong-Mok
    Lee, Hye Lim
    Choi, Kyomin
    Huh, So-Young
    Jang, Myoung-jin
    Min, Ju-Hong
    Kim, Byoung Joon
    Kim, Sung-Min
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (10): : 800 - 805
  • [40] Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
    Park, Su Yeon
    Kwon, Young Nam
    Kim, Sunyoung
    Kim, Seung-Hyun
    Kim, Jong Kuk
    Kim, Jun-Soon
    Nam, Tai-Seung
    Min, Young Gi
    Park, Kyung Seok
    Park, Jin-Sung
    Seok, Jin Myoung
    Sung, Jung-Joon
    Sohn, Eunhee
    Shin, Kyong Jin
    Shin, Jin-Hong
    Shin, Ha Young
    Oh, Seong-il
    Oh, JeeYoung
    Yoon, Byeol-A
    Lee, SangGon
    Lee, Jong-Mok
    Lee, Hye Lim
    Choi, Kyomin
    Huh, So-Young
    Jang, Myoung-jin
    Min, Ju-Hong
    Kim, Byoung Joon
    Kim, Sung Min
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 950 - 951
12345